Cognitive Intervention With Go and Chess in Early and Subjective Cognitive Decline

NCT ID: NCT06281652

Last Updated: 2024-03-01

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

80 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-02-13

Study Completion Date

2025-02-13

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this clinical trial\]is to evaluate if learning to play traditional board games could improve cognition in subjects with mild cognitive impairment and subjective cognitive decline. The main questions it aims to answer are:

* Do Go and Chess improve cognition?
* Is a game better than the other? Is the effect of both games on cognition synergistic?
* Do Go and Chess improve quality of life?
* Do Go and Chess improve mood?
* Do Go and Chess improve lifestyle?

Participants will be randomized to one of four groups:

* Group intervention with Go, once a week, for 12 weeks
* Group intervention with Chess, once a week, for 12 weeks
* Group intervention with Go and Chess, twice a week, for 12 weeks
* Control group

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Mild Cognitive Impairment Subjective Cognitive Decline

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Go classes

Subjects randomized to a group intervention with Go lessons once a week for 12 weeks

Group Type EXPERIMENTAL

Go classes

Intervention Type OTHER

Classes of board games (Go), performed in groups of 6-10 subjects, once a week

Chess classes

Subjects randomized to a group intervention with Chess lessons once a week for 12 weeks

Group Type EXPERIMENTAL

Chess classes

Intervention Type OTHER

Classes of board games (Chess), performed in groups of 6-10 subjects, once a week

Go & Chess classes

Subjects randomized to a group intervention with Go and Chess lessons twice a week for 12 weeks

Group Type EXPERIMENTAL

Go classes

Intervention Type OTHER

Classes of board games (Go), performed in groups of 6-10 subjects, once a week

Chess classes

Intervention Type OTHER

Classes of board games (Chess), performed in groups of 6-10 subjects, once a week

Control

Subjects randomized to no intervention for 12 weeks

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Go classes

Classes of board games (Go), performed in groups of 6-10 subjects, once a week

Intervention Type OTHER

Chess classes

Classes of board games (Chess), performed in groups of 6-10 subjects, once a week

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Diagnosis of mild cognitive impairment or subjective cognitive decline
* Willingness to participate in the board games classes
* Living within 20-minute driving distance from the center
* Signed informed consent

Exclusion Criteria

* Prior knowledge of the the game rules (in case the subject knows one of the two, they can be randomized to the other one)
* Significant linguistic or sensory impairment (according to clinical judgment)
* Significant behavioral or psychiatric disturbances (according to clinical judgment)
* Significant medical comorbidities (according to clinical judgment)
Minimum Eligible Age

55 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Milano Bicocca

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Lucio Tremolizzo, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

Fondazione IRCCS San Gerardo

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Fondazione IRCCS San Gerardo dei Tintori

Monza, Lombardy, Italy

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Italy

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Lucio Tremolizzo, MD, PhD

Role: CONTACT

+390392339082

Federico Emanuele Pozzi, MD

Role: CONTACT

+390392339082

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Lucio Tremolizzo, MD, PhD

Role: primary

+390392339082

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Cognichess

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Tablet-based Cognitive Training
NCT04452864 COMPLETED NA
Exergaming Revolution in Dementia
NCT06631742 RECRUITING NA